Source: IOL Author: Kelly Jane Turner 

Cape Town – South African Health Products Regulatory Authority (Sahpra) has announced it will allow a controlled compassionate use of Ivermectin to treat Covid-19.

The health product regulator says it will unveil the access protocols for the drug in the coming days.

The announcement was made during a press announcement in collaboration with the National Press Club on Wednesday.

“We at Sahpra have considered all of this, and the approach that we will be taking going forward is that we will facilitate a controlled, compassionate, access programme for Ivermectin.

“This does not mean that our position changes around the lack of availability of scientific data, but we had to as a regulator have very in-depth discussions around the context which we find ourselves in with the pandemic with limited options,” said Sahpra chief executive Dr Boitumelo Semete-Makokotlela.

“We hope the controlled access will enable us that the product is used properly and limit the black market,” she said

“It’s important to note that Sahpra has listened and heard what people have been saying about Ivermectin.The programme will be open to all patients. We will review every application as it comes through,” said Semete-Makokotlela.

She said healthcare professionals would be central to the application for use in their patients but will unveil the process in more detail in the coming days.

During a hearing before the US senate homeland security and governmental affairs committee last week, Dr Pierre Kory, a pulmonary and critical care specialist at Aurora St Luke’s Medical Center in Milwaukee, described Ivermectin as a “wonder drug” with immensely powerful antiviral and anti-inflammatory agents.

Kory said: “Ivermectin is highly safe, widely available, and low cost. Its discovery was awarded the Nobel Prize in medicine, and is already included on the WHO’s World’s List of Essential Medicines. Ivermectin is effectively a miracle drug against Covid-19.”









Related:
What is Ivermectin? Study shows ‘head lice meds’ cut COVID-19 deaths by 83%

Ivermectin for Covid-19: Database of all Ivermectin COVID-19 studies – 35 trials and growing

The FLCCC Alliance— On a mission to Save Thousands & Slow the Pandemic

COVID-19: A realistic approach to community management – HCQ & IVM in concert with vaccination

Top US medics recommend ‘sequenced multidrug therapy’ including HCQ & Ivermectin, for early high-risk COVID-19 infections

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Trouble in Paradise Surrounding the use of Ivermectin

In nations around the world tension mounts between physicians and caregivers seeking to prescribe what they professionally deem as safe doses of ivermectin, as an off-label treatment for COVID-19 and national health authorities, which for the most part have all taken a hostile and oppositional position against the use of the drug.

Read More »

How Ivermectin became a Target for the ‘Fraud Detectives.’

And why is ivermectin being so negatively targeted by Big Tech and Big Media? One could argue conflict of interest plays a major role, given how intertwined they are with Big Pharma and the far-reaching grasp of the BMGF. A cheap and effective early treatment for Covid-19, like ivermectin, can be seen as a significant threat to the financial interests of those involved with Covid vaccines and expensive anti-viral drugs.

Read More »

Canada: Alberta Failing on COVID-19 Vaccines and Treatment

Numerous studies and clinical observation of thousands of patients has indicated that Ivermectin is highly effective in this regard. Even low dose studies that were designed to reach the conclusion that ivermectin was not effective found a signal that indicated that Ivermectin effectively interacted with the COVID virus molecule to prevent or lessen replication of the virus.”

Read More »